Press Releases - 2021-07-20

Date	Title	Company
20-Jul-2021	Direct Biologics Announces FDA Approval for Proceeding With Second ExoFlo IND for Post-Acute COVID-19 Syndrome and Chronic Post-COVID-19 Syndrome	Newswire
20-Jul-2021	BIAL AND MEDIS ENTERED INTO A PARTNERSHIP FOR INNOVATIVE MEDICINES FOR THE CENTRAL NERVOUS SYSTEM	Bial
20-Jul-2021	Half Year Trading Update	ALLIANCE PHARMA PLC
20-Jul-2021	PANAKÈS PARTNERS ANNOUNCES THE FIRST CLOSING OF ITS NEW “PURPLE” GLOBAL BIOTECH/ MEDTECH FUND AT €150 MILLION ($180 MILLION)	Panakès
20-Jul-2021	MorphoSys gains enterprise supply chain agility in only eight weeks	MorphoSys
20-Jul-2021	Bachem recognised as a winner at the Swiss Biotech Success Stories Awards 2021	Bachem
20-Jul-2021	CARMAT announces the first commercial implant of its Aeson® artificial heart	CARMAT
20-Jul-2021	Acute Care and Mental Health Recovery Summit: Breakthrough Learnings Through Collaboration	RwHealth
20-Jul-2021	SP’s fill-finish system chosen by NIBRT to deliver advanced training in biopharmaceutical production	SP Scientific Products (SP)
20-Jul-2021	ISA Pharmaceuticals, in partnership with Erasmus MC, is awarded TKI grant and expands clinical pipeline	ISA Pharmaceuticals
20-Jul-2021	Almirall receives European Commission approval of Klisyri®▼ (tirbanibulin), an innovative topical treatment for actinic keratosis	Almirall
20-Jul-2021	PureTech Founded Entity Gelesis, the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp.	PureTech
20-Jul-2021	Subscription to raise £1,000,000 to progress proprietary TYK2/JAK1 programmes into clinical development	Sareum Holdings plc
20-Jul-2021	Diagnostics firms race to reach the ‘holy grail’ of Covid testing	Snedden Campbell
20-Jul-2021	Launching today: eLearning programme to support advanced therapy training in the NHS, UK universities and government bodies	Advanced Therapy Treatment Centre (ATTC)
20-Jul-2021	Bone Therapeutics provides update on the progress of clinical studies	Bone Therapeutics
20-Jul-2021	Sputnik V vaccine against coronavirus authorized in Nigeria	Russian Direct Investment Fund
20-Jul-2021	RxCelerate Establishes Venture Capital Division and Makes First Investment in US Metabolic Disease Company	Newswire
20-Jul-2021	Paradigm4 launches REVEAL: Multi-Omics app for advanced cross-study analyses	Paradigm4
20-Jul-2021	Almost 70% of Doctors Say Covid-19 Vaccine Rates Would Be Higher If They Could Administer to Their Own Patients, New Survey Shows	B3C newswire